Trials / Completed
CompletedNCT07113431
Partial-enteral Nutrition Protocol for Crohn's Disease
A Novel Partial-enteral Nutrition Protocol to Improve Nutrition Status of Adults Patients Experiencing a Crohn's Disease Flare and Starting New Immunologic Therapy.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Kate Farms Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A novel dietary intervention combining a standardized IBD diet (IBD-AID) with supplementation from a pea protein plant-based oral nutrition supplement (ONS) (Kate Farms Peptide 1.5) to improve protein, calorie, and nutrient intake in adult patients experiencing a Crohn's disease flare starting new immunologic therapy. Additionally, this study will include objective measures of body composition to improve nutrition status assessment and provide a more sensitive measure of intervention efficacy compared to anthropometric measures of body weight or BMI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | IBD-AID diet combined with Kate Farms Peptide 1.5 | Combining standardized-IBD diet developed by the University of Minnesota (IBD-AID) with commercially available pea protein plant-based enteral nutrition formula (Kate Farms Peptide 1.5) |
| OTHER | IBD-AID diet | Standardized IBD diet developed by the University of Massachusetts Medical School (IBD-AID) |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2025-10-24
- Completion
- 2025-10-24
- First posted
- 2025-08-08
- Last updated
- 2025-12-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07113431. Inclusion in this directory is not an endorsement.